SAPIEN 3 | ACURATE neo | Evolut R | Lotus | P value | |
n=382 | n=189 | n=157 | n=63 | ||
30-day mortality | 15 (3.9) | 3 (1.6) | 7 (4.5) | 5 (7.9) | 0.105 |
Major vascular complication | 15 (3.9) | 2 (1.1) | 4 (2.5) | 5 (7.9) | 0.042 |
Major/life-threatening bleeding | 21 (5.5) | 4 (2.1) | 3 (1.9) | 6 (9.5) | 0.019 |
Stroke | 8 (2.1) | 3 (1.6) | 5 (3.2) | 3 (4.8) | 0.397 |
Early safety | 38 (9.9) | 7 (3.7) | 14 (8.9) | 12 (19.0) | 0.002 |
New permanent pacemaker* | 36 (11.3) | 18 (10.4) | 31 (21.8) | 20 (37.7) | <0.001 |
ΔPmean post TAVI (mm Hg) | 12.3±4.7 | 9.2±3.9 | 8.6±4.3 | 13.5±5.0 | <0.001 |
Values are n (%) or mean±SD.
*Patients with pre-existing pacemaker were excluded from these calculations.
TAVI, transcatheter aortic valve implantation.